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Supplementary Figure S1. Plasmid map of pCS321, the Rnt1p hairpin characterization plasmid. 
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Supplementary Figure S2. Sequences illustrating the placement of the TCT-4 aptamer within R31L-3B4Inv at multiple locations. 
RS2 and RS3 resulted in nonfunctional switches that were unresponsive to theophylline (data not shown), while RS was functional 
and utilized as the base Rnt1p switch design in this study. Gray lettering is used to indicate the nucleotides in RS2 and RS3 that differ 
from RS. 
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Supplementary Figure S3. The dose response curves of RS, RS-B03, RS-B05, and RS-B06 indicate that these synthetic BSB 
modules increase baseline expression relative to the original Rnt1p switch (RS). These switches exhibit a reduced fold-change relative 
to that exhibited by RS. Data are reported as indicated in Figure 1C. The model parameters for the curve fit are provided in Table I. 
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Supplementary Table 1. Oligonucleotide template sequences for all switches built in this study. The sequences of the indicated 
primers are provided in the Materials and Methods section. 
switch forward primer reverse primer template 
SR SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTCATGAGTC
CATGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SRN SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTCATGCATC
CATGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SRnt SRnt_fwd SR_rev 
AAACAAACTTGATGCCATTGGCAGCCGGATGTCATGAGTC
CATGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-theo2 SR-theo2_fwd SR-theo2_rev 
AAACAAACTTGGCCCTTGGCAGCCGGATGTCATGAGTCCA
TGGCATCTGGATACCAGCCGTAAAAAGAAAAATAAA 
SR-theo3 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCACGATGTCATGAGTC
CATGGCATCGTGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B03 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTTGAAAGTC
TTCAGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B05 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTTGTAAGTC
TACGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B06 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTAATGAGTC
CATTGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B07 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTTGTGAGTC
CACAGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B12 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTAGTGAGTC
CACTGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SRx2 SRx2_fwd SRx2_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTCATGAGTC
CATGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SRx3 SRx3_fwd SRx3_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTCATGAGTC
CATGGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B07x2 SRx2_fwd SRx2_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTTGTGAGTC
CACAGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-B12x2 SRx2_fwd SRx2_rev 
AAACAAACTTGATGCCCTTGGCAGCCGGATGTAGTGAGTC
CACTGCATCTGGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-theo3-B07 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCACGATGTTGTGAGTC
CACAGCATCGTGATACCAGCATCGTAAAAAGAAAAATAAA 
SR-theo3-B12 SR_fwd SR_rev 
AAACAAACTTGATGCCCTTGGCAGCACGATGTAGTGAGTC
CACTGCATCGTGATACCAGCATCGTAAAAAGAAAAATAAA 
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Supplementary Table 2. The theoretical fold-change and dynamic range of all Rnt1p switches examined in this study as determined 
from experimentally measured baseline expression at 0 mM theophylline (b) and the theoretical maximal output (M) calculated by 
fitting the dose response data to the binding model. 
switch b=Y(0mM) M 
theorectical 
fold-change 
theorectical 
dynamic range 
SR 47% ± 2% 97% ± 1% 2.07 ± 0.08 50% ± 2% 
SR-theo2 52% ± 2% 94% ± 3% 1.79 ± 0.08 41% ± 3% 
SR-theo3 42% ± 2% 101% ± 1% 2.40 ± 0.11 59% ± 2% 
SR-B03 79% ± 4% 105% ± 1% 1.33 ± 0.07 26% ± 4% 
SR-B05 51% ± 1% 104% ± 2% 2.04 ± 0.06 53% ± 2% 
SR-B06 56% ± 5% 108% ± 3% 1.94 ± 0.17 52% ± 6% 
SR-B07 44% ± 2% 112% ± 4% 2.56 ± 0.12 68% ± 4% 
SR-B12 44% ± 2% 101% ± 2% 2.26 ± 0.11 56% ± 3% 
SRx2 20% ± 1% 92% ± 0% 4.54 ± 0.16 71% ± 1% 
SRx3 10% ± 0% 74% ± 1% 7.18 ± 0.32 64% ± 1% 
SR-B07x2 16% ± 1% 89% ± 2% 5.42 ± 0.33 72% ± 2% 
SR-B12x2 22% ± 0% 81% ± 2% 3.69 ± 0.10 59% ± 2% 
SR-theo3-B07 37% ± 2% 103% ± 2% 2.79 ± 0.15 66% ± 3% 
SR-theo3-B12 36% ± 1% 95% ± 2% 2.61 ± 0.11 59% ± 2% 
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Supplementary Table 3. The previously reported gene-regulatory activity of the synthetic BSB modules selected for use in this study 
in the context of the Rnt1p hairpin genetic control element (A02). The data is taken from previous work (A Babiskin and C Smolke, in 
preparation [b]). 
substrate Normalized protein levels (%) Normalized transcript levels (%) 
A02-B00 28% ± 1% 43% ± 8% 
A02-B03 50% ± 2% 53% ± 5% 
A02-B05 25% ± 0% 39% ± 3% 
A02-B06 27% ± 2% 57% ± 2% 
A02-B07 37% ± 3% 51% ± 3% 
A02-B12 27% ± 2% 47% ± 5% 
 
 
